Breaking: Big Disruption Hits 2026 Medicare Advantage Enrollment
For the 2026 plan year, a wave of insurer exits is reshaping the Medicare landscape. A Johns Hopkins Bloomberg School of Public Health analysis published in JAMA estimates that about 2.9 million Medicare Advantage enrollees—roughly 1 in 10—will be disenrolled from their current MA plans as plans exit. The study shows the forced disenrollment rate has surged from about 1% in 2018-2024 to 6.9% in 2025 and an estimated 10% in 2026, underscoring a level of churn not seen in years.
The geographic pattern is uneven. Vermont tops the list, with about 92% of MA enrollees affected, while several states including Idaho, Wyoming, North Dakota, South Dakota, New Hampshire, and Maryland see at least 40% impacted. Analysts note the hit is most pronounced in PPOs, smaller carriers, markets with lower star ratings, and rural regions. Even with disruption, the vast majority of enrollees will still have an alternative MA option available in their area, though the transition can be costly and confusing for households.
What this means for medicare advantage members just navigating renewal season
For medicare advantage members just receiving renewal notices, the scope of disruption is jarring. Renewal materials emphasize replacement plans offered in each region, but the real question is cost, coverage, and access after a plan terminates. Premiums, drug coverage, and provider networks can change materially when a plan exits, adding to the complexity of the decision for beneficiaries and their families.
'This is a watershed moment for beneficiaries and investors alike,' said a senior health policy analyst at MarketView Partners. 'The churn intensity will test how plans price risk, how networks are maintained, and how smoothly the transition to alternatives—whether another MA plan or a Medigap option—unfolds.'
The Medigap window: a potential safety valve amid upheaval
Federal rules create a six-month Medigap Open Enrollment Period that begins the first month a beneficiary has Part B and is 65 or older. When a Medicare Advantage plan ends, this period can offer a rare guaranteed-issue opportunity to buy certain Medigap policies without medical underwriting. That safeguard is a critical consideration for anyone forced to switch away from their MA plan, because it can affect premiums and eligibility for coverage in the near term.
- Guaranteed-issue status means insurers can't deny coverage or impose medical underwriting for eligible Medigap plans during the window.
- The window begins when Part B is active and the person turns 65 or older, and it applies to a subset of Medigap plans depending on the state and carrier.
- Outside the window, Medigap underwriting or tighter underwriting standards can apply, potentially altering costs and eligibility.
Why the shift matters for investors and insurer strategy
The 2026 disruption puts a premium on plan design, pricing discipline, and market exits. Insurance executives and analysts expect several key dynamics to unfold:
- Premium resilience: Plans facing higher churn may adjust premiums to offset the cost of replacing enrollees who leave mid-year or mid-cycle.
- Network and provider strategy: Carriers may renegotiate networks, impacting access and satisfaction metrics that drive star ratings and member retention.
- Product mix shifts: A surge in Medigap enrollments during the guaranteed-issue window could alter risk pools and profitability for both MA and Medigap lines.
Analysts warn investors to watch insurer earnings calls for commentary on 2026 disenrollments, plan terminations, and their impact on premium growth. 'The revenue impact will hinge on whether carriers can successfully attract switching MA members or attract new Medigap customers,' said a veteran health equities strategist. 'Policy changes and enrollment timing will be key drivers of near-term stock volatility across the health insurers.'
Strategic takeaways for medicare advantage members just charting plans
As the renewal cycle unfolds, individuals facing plan changes should take decisive steps to protect coverage and costs. The immediate tasks include comparing replacement MA options in the local market, evaluating premium tradeoffs, and considering the Medigap open enrollment window as a potential safety net.
First, map out options:
- Identify all MA plans available in your area, focusing on premium cost, drug coverage, and the network of preferred providers.
- Check whether any replacement MA plan has a similar or better star rating and whether your preferred clinicians are in-network.
- Estimate total costs, including premiums, copays, and out-of-pocket maximums, for the plans you compare.
Second, consider Medigap as a bridge. A six-month window can simplify the path to guaranteed-issue coverage, especially for seniors navigating the shift away from MA plans. Contact Medigap issuers early to understand eligibility, plan options, and pricing within the open enrollment period. The goal is to avoid delayed coverage or gaps in drug benefits during a period of transition.
Market watch: a closer look at insurer exposure
Among large players, market observers will be monitoring how individual insurers manage this churn. Stocks of major health insurers often react to renewal rate guidance, plan terminations, and the pace of enrollment changes. The turbulence could underscore a broader investor theme: the value of diversified product lines, growth through new enrollments, and disciplined underwriting during a period of elevated churn.
'For medicare advantage members just beginning to reassess coverage, the timing of plan terminations matters as much as the cost,' noted a senior equity analyst. 'Companies that can sustain favorable risk pools and deliver predictable guidance amid renewals will emerge with a competitive edge.'
What families should do now
With October renewal letters arriving, households should take a structured approach:
- Collect all MA plan notices and price quotes from competing plans before the deadline.
- Track the exact timing of disenrollment notices to align renewal decisions with coverage needs.
- Consult with a licensed advisor who understands MA-to-Medigap transitions and can compare plan costs side-by-side.
Bottom line: a major shift with lasting implications
The 2026 Medicare Advantage disruption is a turning point for beneficiaries and investors alike. While most affected adults will still find an alternative plan in their area, the path is no longer straightforward. The combination of plan terminations, network changes, and a potential surge in Medigap enrollments creates a complex landscape for pricing, benefits, and investor expectations.
For medicare advantage members just beginning to navigate renewal season, the focus should be on timely plan comparisons, understanding the Medigap enrollment window, and securing coverage that protects health needs while managing costs. And for investors watching the sector, the unfolding renewals will likely shape metrics like enrollment growth, premium trends, and the efficiency with which insurers absorb churn in a shifting market.
In a climate where medicare advantage members just face higher uncertainty, proactive planning—and clear information about the options—will be the difference between a smooth transition and costly missteps. As the year progresses, stakeholders will closely track renewal notices, plan terminations, and the Medigap enrollment window to gauge how this episode reshapes coverage, pricing, and returns.
Discussion